Alnylam Pharmaceuticals, Inc. (ALNY)
236.47
-2.53
(-1.06%)
USD |
NASDAQ |
Aug 27, 16:00
236.47
0.00 (0.00%)
After-Hours: 18:34
Alnylam Pharmaceuticals EPS Diluted (TTM) : 5.923 for June 30, 2026
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 5.923 |
| March 31, 2026 | 4.163 |
| December 31, 2025 | 2.514 |
| September 30, 2025 | 0.4975 |
| June 30, 2025 | -2.210 |
| March 31, 2025 | -1.790 |
| December 31, 2024 | -2.172 |
| September 30, 2024 | -2.621 |
| June 30, 2024 | -0.6018 |
| March 31, 2024 | -2.683 |
| December 31, 2023 | -3.563 |
| September 30, 2023 | -4.148 |
| June 30, 2023 | -8.623 |
| March 31, 2023 | -8.703 |
| December 31, 2022 | -9.297 |
| September 30, 2022 | -9.772 |
| June 30, 2022 | -8.165 |
| March 31, 2022 | -7.480 |
| December 31, 2021 | -7.195 |
| September 30, 2021 | -7.131 |
| June 30, 2021 | -7.598 |
| March 31, 2021 | -7.549 |
| December 31, 2020 | -7.454 |
| September 30, 2020 | -7.831 |
| June 30, 2020 | -7.566 |
| Date | Value |
|---|---|
| March 31, 2020 | -8.028 |
| December 31, 2019 | -8.137 |
| September 30, 2019 | -7.758 |
| June 30, 2019 | -8.273 |
| March 31, 2019 | -7.879 |
| December 31, 2018 | -7.566 |
| September 30, 2018 | -6.953 |
| June 30, 2018 | -5.860 |
| March 31, 2018 | -5.577 |
| December 31, 2017 | -5.411 |
| September 30, 2017 | -5.251 |
| June 30, 2017 | -5.121 |
| March 31, 2017 | -4.827 |
| December 31, 2016 | -4.79 |
| September 30, 2016 | -4.54 |
| June 30, 2016 | -4.24 |
| March 31, 2016 | -4.04 |
| December 31, 2015 | -3.45 |
| September 30, 2015 | -2.66 |
| June 30, 2015 | -2.33 |
| March 31, 2015 | -2.06 |
| December 31, 2014 | -5.14 |
| September 30, 2014 | -5.37 |
| June 30, 2014 | -5.27 |
| March 31, 2014 | -4.98 |
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Ionis Pharmaceuticals, Inc. | -3.473 |
| Regeneron Pharmaceuticals, Inc. | 40.46 |
| Vertex Pharmaceuticals, Inc. | 17.19 |
| BridgeBio Pharma, Inc. | -3.569 |
| Pfizer Inc. | 0.7552 |